Administration of lipoic acid (200 to 1,800 mg/day for 2 weeks to 1 year), alone or together with other nutrients, was found to lower fasting blood glucose and insulin concentrations, insulin resistance, and blood HbA1c concentration a marker of glycemic control over the past few months (60)
SF at the higher dose treatment resulted in both acute and long-term beneficial effects, including upregulation of the phase 2 antioxidant response at the injury site, decreased mRNA levels of inflammatory cytokines in the injured spinal cord, inactivation of urinary macrophage MIF tautomerase activity (which is thought to act by blocking its interaction with the CD74 receptor of macrophages), and by enhancing hindlimb locomotor function, and an increased number of serotonergic axons caudal to the lesion site [248]
Most known TAAs are CTL (cytotoxic T lymphocyte also known as CD8+ T-cells or killer T cell) epitopes [64]
But it failed to demonstrate significant weight loss in six clinical trials, and its development was terminated because of those failures
